60 Degrees Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
2.66M
on 2026-06-30, from 49K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-09-19. Not read yet. S-3 ↗
$981K
Agreement of 2026-03-13. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
13K
Warrants of every class as tagged in the XBRL facts on 2023-09-30. Adjusted for three reverse splits. 10-Q ↗
Cash
0.5 quarters
$1.0M on 2026-06-30 ÷ $2.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-30 | Private placement incl. 0.38M pre-funded | 574,713 | $1.74 | $1.0M | 8-K ↗ |
| 2025-07-15 | Public offering incl. 0.88M pre-funded, with warrants at $1.90 | 2,631,578 | $1.90 | $5.0M | 424B4 ↗ |
| 2025-07-15 | Private placement incl. 0.88M pre-funded | 1,756,528 | not read | $5.0M | 8-K ↗ |
| 2025-02-05 | Public offering | 1,503,500 | $0.715 | $1.1M | 424B5 ↗ |
| 2025-01-28 | Public offering | 1,021,549 | $1.021 | $1.0M | 424B5 ↗ |
Also on file: a 1-for-4 reverse split, 2026-01-14 8-K ↗